GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD.
🇹🇼Taiwan
Clinical Trials
5
Active:1
Completed:3
Trial Phases
2 Phases
Phase 1:3
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 2
2 (40.0%)An Open-labeled Phase II Study to Evaluate the Efficacy and Safety of GXNPC-1 in Patients With Chronic Stroke
- First Posted Date
- 2019-09-12
- Last Posted Date
- 2023-04-11
- Lead Sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT04088149
- Locations
- 🇨🇳
HualienTzu Chi Hospital, Hualien City, Taiwan
A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis
- First Posted Date
- 2019-09-12
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04088058
- Locations
- 🇨🇳
HualienTzu Chi Hospital, Hualien City, Taiwan
🇨🇳National Taiwan University Hospital, Taipei county, Taiwan
Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis
- First Posted Date
- 2019-05-09
- Last Posted Date
- 2023-06-06
- Lead Sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT03943576
- Locations
- 🇨🇳
GWOXI Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke
Phase 1
Completed
- Conditions
- Stroke
- Interventions
- Drug: ADSCs
- First Posted Date
- 2016-06-27
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Target Recruit Count
- 3
- Registration Number
- NCT02813512
- Locations
- 🇨🇳
Gwo Xi Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan
🇨🇳Hualien Tzu Chi Hospital, Hualien city, Taiwan
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis
Phase 1
Completed
- Conditions
- Liver Cirrhosis
- Interventions
- Drug: ADSCs
- First Posted Date
- 2014-11-21
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT02297867
- Locations
- 🇨🇳
China Medical University Beigang Hospital, Taichung, Beigang, Taiwan
🇨🇳Gwo Xi Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan
News
No news found